Douglas Pharmaceuticals Revenue and Competitors

NZ

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Douglas Pharmaceuticals's estimated annual revenue is currently $148.9M per year.(i)
  • Douglas Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Douglas Pharmaceuticals has 741 Employees.(i)
  • Douglas Pharmaceuticals grew their employee count by 4% last year.

Douglas Pharmaceuticals's People

NameTitleEmail/Phone
1
Account Manager - CMO Vendors and CustomersReveal Email/Phone
2
Head Remuneration & People SystemsReveal Email/Phone
3
Head LearningReveal Email/Phone
4
Quality Assurance OfficerReveal Email/Phone
5
Purchasing OfficerReveal Email/Phone
6
Head EngineeringReveal Email/Phone
7
Head Clinical ResearchReveal Email/Phone
8
Purchasing OfficerReveal Email/Phone
9
Purchasing OfficerReveal Email/Phone
10
Head Technical Process EngineeringReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24.3M1215%N/AN/A
#2
$18.9M94-3%N/AN/A
#3
$62.7M3124%N/AN/A
#4
$95.3M474N/AN/AN/A
#5
$148.9M7414%N/AN/A
#6
$14.7M730%N/AN/A
Add Company

What Is Douglas Pharmaceuticals?

Douglas Pharmaceuticals is one of the fastest growing pharmaceutical companies in Australasia. Outstanding customer service is the key to the success of Douglas Pharmaceuticals with the company being consistently ranked as the top performing company in the New Zealand IMS surveys on pharmacist satisfaction. Considerable investment in product development laboratories and a specifically designed containment suite for steroid manufacture signals the company's intention to present it's international clients with high quality products, supported through the timely provision of fully compliant registration dossiers in CTD format.

keywords:N/A

N/A

Total Funding

741

Number of Employees

$148.9M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Douglas Pharmaceuticals News

2022-04-20 - Avadel Pharmaceuticals Announces Interim Data for FT218 as ...

Avadel Pharmaceuticals announced the presentation of interim data from ... switched from the twice-nightly formulation,” Douglas Williamson,...

2022-04-19 - US Psychedelic Drugs Market Is Expected To Reach USD ...

(US), NeuroRx, Inc. (US), Jazz Pharmaceuticals, Inc. (Ireland), COMPASS (UK), Develco Pharma Schweiz AG (Switzerland), Douglas...

2022-03-30 - Douglas Melton, noted stem cell researcher, leaves Harvard ...

Douglas Melton, one of the leading stem cell researchers in the world, is leaving Harvard University to join Vertex Pharmaceuticals,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$186.7M7415%N/A
#2
$280.1M741N/AN/A
#3
$186.7M74120%N/A
#4
$186.7M741N/AN/A
#5
$75M7434%N/A